No shortage on file

JAMP TELMISARTAN-HCT

JAMP PHARMA CORPORATION

Quick answers

Is there a shortage of JAMP TELMISARTAN-HCT in Canada?

No. There is no current shortage of JAMP TELMISARTAN-HCT 12.5MG 80MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-13

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Jamp Telmisartan-HCT tablet

Jamp Telmisartan-HCT tablet; Out-of-Specification (Assay)

Type II2024-09-11

Moderate health risk

Possible match — not confirmed

JAMP TELMISARTAN-HCT

JAMP TELMISARTAN-HCT: Affected lots may contain higher dosage than the labelled dose

Type II2024-01-24

Moderate health risk

Possible match — not confirmed

DIN

02389940

Strength

12.5MG 80MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE TELMISARTAN

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-10-30

Resolved

Disruption of the manufacture of the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

5MG · DIN 02429217

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225